Deals
Existing backers such as Blume Ventures, Analog Capital, Elev8, IndiaMART, and Kae Capital also participated.
1
Seven key metrics that defined Grab’s first profitable year
2
Green Li-ion cuts losses by 44% in FY2025, eyes profitability in 2026
3
Japan Post Bank tops full-year alternative investment target by Q3
4
ByteDance in talks to sell gaming unit Moonton for over $6b
5
China says semiconductor supply chain stability top priority after Dutch ruling on Nexperia
More Stories
Singapore to roll out second tranche of $1.2-billion Anchor Fund
How Singapore’s markets are primed for 2026
65 Equity-backed UltraGreen.ai debuts on SGX after $400m IPO
CVC in early talks to invest in Indonesian retail conglomerate MAP Group
Moladin, Xendit said to have trimmed workforce in latest tech reset
Policy & Regulations
The exposure should be limited to 10% of the bank’s capital base.
The deal will give Alkem MedTech access to high-value markets.
Earnings and Results
Lower manufacturing costs for its new lineup of models helped partly offset a sales slump.
Venture Capital
With Fund II, W Health plans to build and scale 8-10 new companies over the next four years.
Private Equity
The category II alternative investment fund is targeting a total corpus of Rs 5,000 crore.
The company serves customers across over 19,000 pin codes in India.
IPOs & Markets
In April 2025, the company had raised 5 billion rupees through a similar issue.
People
The hiring push would double UBS’s workforce in Hyderabad.
Its revenue rose 38.8% to Rs 23.08 billion, outweighing total expenses which rose 28% to Rs 16.9 billion.
